CuriosityStream Reports Strong Q4 & FY25 Results, Expands Share Repurchase Program to $6 Million
CURI sits 55% above its 52-week low of $2.06 on elevated volume (2.5× avg).
Summary
CuriosityStream reported strong Q4 and full-year 2025 financial results, including significant revenue growth and a shift to positive Adjusted EBITDA and free cash flow, alongside an expanded $6 million share repurchase authorization.
Key Events · Earnings and Guidance · CURI
-
Strong Q4 and Full Year 2025 Financial Performance
The company reported Q4 2025 revenue of $19.2 million, a 36% increase year-over-year, and full-year 2025 revenue of $71.7 million, up 40% from 2024. Gross margins also expanded significantly.
-
Shift to Positive Adjusted EBITDA and Free Cash Flow
CuriosityStream achieved positive Adjusted EBITDA of $1.1 million in Q4 2025 and $8.2 million for the full year, a substantial improvement from losses in the prior year. Net cash provided by operating activities and Adjusted Free Cash Flow also turned positive and grew.
-
Expanded Share Repurchase Program
The Board of Directors authorized an additional $2.0 million for share repurchases, increasing the total approved amount under the existing program to $6.0 million. This represents a significant commitment to returning value to shareholders.
-
Positive Financial Outlook for H1 2026
The company provided guidance for the first half of 2026, expecting revenue between $38 million and $42 million, and Adjusted Free Cash Flow between $6 million and $9 million.
Analysis · CURI · Trade & Services
CuriosityStream Inc. delivered robust financial results for both the fourth quarter and full year 2025, demonstrating significant revenue growth and a crucial shift to positive Adjusted EBITDA and free cash flow. This operational improvement, coupled with the Board's decision to expand the share repurchase program to a substantial $6 million (over 3% of current market cap), signals strong management confidence and a commitment to shareholder value. The positive outlook for the first half of 2026 further reinforces the company's improving financial trajectory, making this a highly positive and market-moving announcement.
At the time of this filing, CURI was trading at $3.20 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $190.6M. The 52-week trading range was $2.06 to $7.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.